Prognosis
Thai Premier Delays AstraZeneca Shot Over Probe Into Blood Clots
- Temporary halt follows reports of blood clots after the shot
- European regulators still back vaccine as review is underway
This article is for subscribers only.
Thailand joined Italy and a number of other European nations in temporarily suspending the use of AstraZeneca Plc’s Covid-19 vaccine pending an investigation into whether it may trigger blood clots.
The decision comes even as European regulators renewed their support of the immunization developed by Cambridge-based AstraZeneca and the University of Oxford, saying there was no indication the shot caused the clots that occur in thousands of people every year.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
Thai Premier Delays AstraZeneca Shot Over Probe Into Blood Clots